RJFSA
ARKG icon

Raymond James Financial Services Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Raymond James Financial Services Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.45M Sell
56,471
-6,103
-10% -$155K ﹤0.01% 1921
2024
Q2 		$1.47M Sell
62,574
-20,586
-25% -$520K ﹤0.01% 1849
2024
Q1 		$2.39M Sell
83,160
-12,789
-13% -$385K ﹤0.01% 1552
2023
Q4 		$3.15M Sell
95,949
-10,776
-10% -$293K 0.01% 1326
2023
Q3 		$2.97M Sell
106,725
-5,853
-5% -$191K 0.01% 1284
2023
Q2 		$3.84M Sell
112,578
-190,039
-63% -$5.97M 0.01% 1165
2023
Q1 		$9.1M Buy
302,617
+14,521
+5% +$450K 0.02% 737
2022
Q4 		$8.13M Sell
288,096
-16,749
-5% -$532K 0.02% 739
2022
Q3 		$10M Sell
304,845
-152,628
-33% -$5.6M 0.02% 613
2022
Q2 		$14.4M Buy
457,473
+215,575
+89% +$7.54M 0.03% 508
2022
Q1 		$11.1M Sell
241,898
-9,505
-4% -$453K 0.02% 647
2021
Q4 		$15.4M Sell
251,403
-93,924
-27% -$6.49M 0.03% 525
2021
Q3 		$25.8M Buy
345,327
+31,230
+10% +$2.62M 0.05% 351
2021
Q2 		$29.1M Sell
314,097
-61,000
-16% -$5.19M 0.06% 321
2021
Q1 		$33.3M Buy
375,097
+83,159
+28% +$8.25M 0.08% 267
2020
Q4 		$27.2M Buy
291,938
+104,887
+56% +$8.36M 0.07% 280
2020
Q3 		$11.9M Sell
187,051
-16,646
-8% -$975K 0.03% 447
2020
Q2 		$10.6M Buy
203,697
+39,440
+24% +$1.69M 0.03% 446
2020
Q1 		$5.14M Buy
164,257
+64,541
+65% +$2.16M 0.02% 538
2019
Q4 		$3.34M Buy
99,716
+36,628
+58% +$1.16M 0.01% 900
2019
Q3 		$1.86M Buy
63,088
+19,711
+45% +$641K 0.01% 1141
2019
Q2 		$1.5M Sell
43,377
-61,773
-59% -$1.98M 0.01% 1262
2019
Q1 		$3.46M Buy
105,150
+81,244
+340% +$2.4M 0.01% 798
2018
Q4 		$573K Buy
23,906
+14,495
+154% +$408K ﹤0.01% 1581
2018
Q3 		$315K Buy
+9,411
New +$298K ﹤0.01% 2244

Other funds holding ARKG

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Raymond James Financial Services Advisors's ARKG Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its ARK Genomic Revolution ETF (ARKG) stake by 9.8% in Q3 2024, selling an estimated $155K and leaving 56,471 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #1921.

Raymond James Financial Services Advisors first reported a position in ARKG in Q3 2018 and has held it in 25 quarters since. The position peaked at $33.3M in Q1 2021. 239 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.

  • Raymond James Financial Services Advisors held 56,471 shares of ARK Genomic Revolution ETF worth $1.45M as of Q3 2024.
  • Raymond James Financial Services Advisors sold 6,103 ARK Genomic Revolution ETF shares in Q3 2024, an estimated $155K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #1921 holding.
  • Raymond James Financial Services Advisors first reported a position in ARK Genomic Revolution ETF in Q3 2018 and has held it in 25 quarters since.
  • Raymond James Financial Services Advisors's ARK Genomic Revolution ETF position peaked at $33.3M in Q1 2021.
  • 239 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.